Development and maintenance of bovine cytotoxic lymphocytes with recombinant human interleukin-2.
J Carter(Washington State University), P J Barr(Washington State University), William C. Davis(Washington State University), James E. Talmadge(Nebraska Medical Center), P H Mason(Washington State University), Nancy S. Magnuson(Washington State University), James A. Magnuson(Washington State University)
PubMed
January 1, 1986
Cited by 11
Related Papers
Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer
|American Journal Of Pathology|2007|470
Pim kinase-dependent inhibition of c-Myc degradation
|Oncogene|2008|272
Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis
|Journal of Veterinary Science|2001|268
Pim-1 regulates cardiomyocyte survival downstream of Akt
|Nature Medicine|2007|239
Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase
|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2002|195